Global RiskNews Briefs

EU and Italy Block Export of AstraZeneca Covid-19 Vaccine to Australia

Italy has blocked the export of the Covid-19 vaccine created by AstraZeneca to Australia in coordination with the European Union. The move reflects growing frustration in Europe over vaccine shortages and slow deliveries. Australia is now considered a nonvulnerable country in terms of the Covid-19 pandemic and therefore the EU decided that vaccines should stay within Europe, where countries are still struggling with significant outbreaks.

The decision affected over 250,000 doses, bottled at a factory near Rome. AstraZeneca has allegedly delivered roughly 1.5 million doses to Italy. AstraZeneca representatives have declined to comment on Italy’s decision. The move is the first use of a new EU policy that allows controls to be imposed on the import and export of vaccines. The EU is still struggling to stay up to par with public expectations of a large-scale vaccine rollout that was promised earlier this year.

Read More: EU and Italy Block Export of AstraZeneca Covid-19 Vaccine to Australia

OODA Analyst

OODA Analyst

OODA is comprised of a unique team of international experts capable of providing advanced intelligence and analysis, strategy and planning support, risk and threat management, training, decision support, crisis response, and security services to global corporations and governments.